A Registry for the Research of Primary Tumors of the Spine

Overview

About this study

The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to understand the predictive factors which influence survival, local recurrence, adverse events, perioperative morbidity, and health related quality of life.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria

  • Diagnosed with a primary tumor of the spine and receives medical and/or surgical treatment for the tumor
  • Willing and able to participate in the registry and able to attend follow-up visits, according to the investigator
  • Capable of understanding the content of the patient information and Informed Consent Form
  • Has agreed to participate in the registry by providing consent according to the applicable local law and the declaration of Helsinki

Exclusion Criteria

  • Diagnosed with a metastatic tumor of the spine
  • Diagnosed with a primary spinal cord tumor

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michelle Clarke, M.D.

Open for enrollment

Contact information:

Sandra Twaites

(507)284-5775

Twaites.Sandra@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20304522

Mayo Clinic Footer